Proposed pact highlights genetic diagnostics in cancer treatment
Roche Holding AG agreed to pay $1.03 billion for up to a 56.3% stake in Foundation Medicine Inc. FMI, +3.37% in a collaboration that underscores the growing importance of genetic diagnostics in the treatment and development of drugs for cancer.
19:08 U.S. indicts three Takata executives, fines company $1 billion in faulty air bag scandal15
21:40 HP Enterprise to buy cloud software company SimpliVity2
18:21 Mark Zuckerberg takes the stand in $2 billion lawsuit claiming Oculus theft5
16:16 Luxottica, Essilor $24 billion merger creates eyewear giant17